[HTML][HTML] Update on the epidemiology, genetics, and therapeutic options of hyperuricemia
L Li, Y Zhang, C Zeng - American journal of translational research, 2020 - ncbi.nlm.nih.gov
Hyperuricemia may occur when there is an excess of uric acid in the blood. Hyperuricemia
may result from increased production or decreased excretion of uric acid. Elevated uric acid …
may result from increased production or decreased excretion of uric acid. Elevated uric acid …
[HTML][HTML] The role of the intestine in the development of hyperuricemia
H Yin, N Liu, J Chen - Frontiers in immunology, 2022 - frontiersin.org
Gout is a common inflammatory arthritis caused by the deposition of sodium urate crystals in
the joints. Hyperuricemia is the fundamental factor of gout. The onset of hyperuricemia is …
the joints. Hyperuricemia is the fundamental factor of gout. The onset of hyperuricemia is …
[HTML][HTML] Blockade of autophagy prevents the progression of hyperuricemic nephropathy through inhibiting NLRP3 inflammasome-mediated pyroptosis
Y Hu, Y Shi, H Chen, M Tao, X Zhou, J Li, X Ma… - Frontiers in …, 2022 - frontiersin.org
Hyperuricemia has become a common metabolic disease, and is a risk factor for multiple
diseases, including chronic kidney disease. Our recent study indicated that following …
diseases, including chronic kidney disease. Our recent study indicated that following …
Fucoxanthin: A promising compound for human inflammation-related diseases
M Liu, W Li, Y Chen, X Wan, J Wang - Life sciences, 2020 - Elsevier
Fucoxanthin, a natural product of carotenoids, is a potential drug source obtained from
marine algae. The special chemical structure of fucoxanthin has equipped it with a variety of …
marine algae. The special chemical structure of fucoxanthin has equipped it with a variety of …
Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update
This article aims to critically review the evidence on the available therapeutic strategies for
the treatment of hyperuricemia. For this reason, several papers were reviewed. Xanthine …
the treatment of hyperuricemia. For this reason, several papers were reviewed. Xanthine …
Berberrubine attenuates potassium oxonate-and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway
G Lin, Q Yu, L Xu, Z Huang, L Mai, L Jiang, Z Su… - European Journal of …, 2021 - Elsevier
Abstract Phellodendri Chinensis Cortex (PC) is a traditional medicinal material used to treat
gout and hyperuricemia (HUA) in China. Berberine (BBR), the main component of PC …
gout and hyperuricemia (HUA) in China. Berberine (BBR), the main component of PC …
[HTML][HTML] Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients
This review aims to critically present the available clinical evidence supporting the treatment
of chronic hyperuricemia with xanthine oxidase inhibitors. For this reason, the studies …
of chronic hyperuricemia with xanthine oxidase inhibitors. For this reason, the studies …
[HTML][HTML] Anti-hyperuricemic and nephroprotective effects of dihydroberberine in potassium oxonate-and hypoxanthine-induced hyperuricemic mice
L Xu, G Lin, Q Yu, Q Li, L Mai, J Cheng, J Xie… - Frontiers in …, 2021 - frontiersin.org
Phellodendri Chinese Cortex has long been used to treat hyperuricemia and gout.
Berberine (BBR), its characteristic ingredient, has also been shown to be effective in …
Berberine (BBR), its characteristic ingredient, has also been shown to be effective in …
Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
R Zhao, Z Li, Y Sun, W Ge, M Wang, H Liu, L Xun… - Gut …, 2022 - Taylor & Francis
Hyperuricemia is the second most prevalent metabolic disease to human health after
diabetes. Only a few clinical drugs are available, and most of them have serious side effects …
diabetes. Only a few clinical drugs are available, and most of them have serious side effects …
Management of hyperuricemia in asymptomatic patients: a critical appraisal
A Brucato, F Cianci, C Carnovale - European Journal of Internal Medicine, 2020 - Elsevier
While there is consensus on starting urate-lowering therapy (ULT) in cases of symptomatic
hyperuricemia, the frequent condition of asymptomatic hyperuricemia (AH) remains a …
hyperuricemia, the frequent condition of asymptomatic hyperuricemia (AH) remains a …